Collaborative study on saccharide quantification of the Haemophilus influenzae type b component in liquid vaccine presentations
{{output}}
Before release onto the market, it must be demonstrated that the total and free polysaccharide (poly ribosyl-ribitol-phosphate, PRP) content of Haemophilus influenzae type b (Hib) vaccine complies with requirements. However, manufacturers use different methods... ...
